Paper17526733
Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice.
Kato J and 3 others. Mol Cell Biol, 2007. Cited by 58 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice. Papers, record 17526733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17526733
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholera Toxin | Major topic |
| N-Glycosyl Hydrolases | Major topic |
| Adenosine Diphosphate Ribose | |
| Animals | |
| Body Fluids | |
| Catalysis | |
| Cyclic AMP | |
| Embryo, Mammalian | |
| Exons | |
| GTP-Binding Protein alpha Subunits, Gs | |
| Gene Targeting | |
| Heterozygote | |
| Intestines | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Mutant Proteins | |
| Recombinant Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| Z01HL000659 | NIH | NIH RePORTER | |||
| ZIAHL000659 | NIH | NIH RePORTER |
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,398,961 | Some properties of purified Escherichia coli heat-stable enterotoxin II. | Infect Immun | 1992 | https://conductscience.org/library/papers/1398961 | PubMed |
| 2 | 1,375,222 | Molecular and immunological characterization of ADP-ribosylarginine hydrolases. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1375222 | PubMed |
| 3 | 8,349,667 | Cloning and site-directed mutagenesis of human ADP-ribosylarginine hydrolase. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8349667 | PubMed |
| 4 | 7,896,743 | ADP-ribosylarginine glycohydrolase catalyzing the release of ADP-ribose from the cholera toxin-modified alpha-subunits of GTP-binding proteins. | J Biochem | 1994 | https://conductscience.org/library/papers/7896743 | PubMed |
| 5 | 7,658,473 | The three-dimensional crystal structure of cholera toxin. | J Mol Biol | 1995 | https://conductscience.org/library/papers/7658473 | PubMed |
| 6 | 8,703,012 | Cloning and characterization of a novel membrane-associated lymphocyte NAD:arginine ADP-ribosyltransferase. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8703012 | PubMed |
| 7 | 9,516,428 | Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9516428 | PubMed |
| 8 | 9,726,960 | Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9726960 | PubMed |
| 9 | 10,358,013 | Identification of critical, conserved vicinal aspartate residues in mammalian and bacterial ADP-ribosylarginine hydrolases. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10358013 | PubMed |
| 10 | 15,893,437 | Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene. | Gene | 2005 | https://conductscience.org/library/papers/15893437 | PubMed |
| 11 | 15,842,200 | Purification, characterization and molecular cloning of glycosylphosphatidylinositol-anchored arginine-specific ADP-ribosyltransferases from chicken. | Biochem J | 2005 | https://conductscience.org/library/papers/15842200 | PubMed |
| 12 | 16,123,042 | Uncoupling Crk signal transduction by Pseudomonas exoenzyme T. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16123042 | PubMed |
| 13 | 16,430,223 | Salmonella enterica SpvB ADP-ribosylates actin at position arginine-177-characterization of the catalytic domain within the SpvB protein and a comparison to binary clostridial actin-ADP-ribosylating toxins. | Biochemistry | 2006 | https://conductscience.org/library/papers/16430223 | PubMed |
| 14 | 11,287,126 | Human placenta hydrolases active on free ADP-ribose: an ADP-sugar pyrophosphatase and a specific ADP-ribose pyrophosphatase. | Biochim Biophys Acta | 2001 | https://conductscience.org/library/papers/11287126 | PubMed |
| 15 | 11,825,615 | Cloning, expression and characterisation of a human Nudix hydrolase specific for adenosine 5'-diphosphoribose (ADP-ribose). | Biochim Biophys Acta | 2002 | https://conductscience.org/library/papers/11825615 | PubMed |
| 16 | 12,070,318 | The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. | Protein Sci | 2002 | https://conductscience.org/library/papers/12070318 | PubMed |
| 17 | 12,790,796 | Mammalian NADH diphosphatases of the Nudix family: cloning and characterization of the human peroxisomal NUDT12 protein. | Biochem J | 2003 | https://conductscience.org/library/papers/12790796 | PubMed |
| 18 | 15,049,684 | Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanism. | Biochemistry | 2004 | https://conductscience.org/library/papers/15049684 | PubMed |
| 19 | 4,335,444 | Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. | J Clin Invest | 1972 | https://conductscience.org/library/papers/4335444 | PubMed |
| 20 | 1,058,471 | Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1058471 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,375,922 | ADP-ribose hydrolases: biological functions and potential therapeutic targets. | Expert Rev Mol Med | 2024 | https://conductscience.org/library/papers/39375922 | PubMed |
| 38,734,665 | Mono-ADP-ribosylation, a MARylationmultifaced modification of protein, DNA and RNA: characterizations, functions and mechanisms. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/38734665 | PubMed |
| 36,839,575 | ADP-Ribosylation in Antiviral Innate Immune Response. | Pathogens | 2023 | https://conductscience.org/library/papers/36839575 | PubMed |
| 36,497,109 | ARH Family of ADP-Ribose-Acceptor Hydrolases. | Cells | 2022 | https://conductscience.org/library/papers/36497109 | PubMed |
| 36,371,029 | The cytopathic activity of cholera toxin requires a threshold quantity of cytosolic toxin. | Cell Signal | 2023 | https://conductscience.org/library/papers/36371029 | PubMed |
| 36,035,988 | Functional roles of ADP-ribosylation writers, readers and erasers. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/36035988 | PubMed |
| 34,976,832 | Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34976832 | PubMed |
| 34,508,355 | TARG1 protects against toxic DNA ADP-ribosylation. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/34508355 | PubMed |
| 33,693,930 | ADP-ribosylation of RNA and DNA: from in vitro characterization to in vivo function. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33693930 | PubMed |
| 32,092,898 | ARH1 in Health and Disease. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32092898 | PubMed |
| 32,029,451 | (ADP-ribosyl)hydrolases: structure, function, and biology. | Genes Dev | 2020 | https://conductscience.org/library/papers/32029451 | PubMed |
| 31,599,159 | The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD+ Hydrolysis. | ACS Chem Biol | 2019 | https://conductscience.org/library/papers/31599159 | PubMed |
| 31,176,616 | Targeting ADP-ribosylation as an antimicrobial strategy. | Biochem Pharmacol | 2019 | https://conductscience.org/library/papers/31176616 | PubMed |
| 30,991,935 | ADP-ribosylation signalling and human disease. | Open Biol | 2019 | https://conductscience.org/library/papers/30991935 | PubMed |
| 30,862,789 | Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation. | Nat Commun | 2019 | https://conductscience.org/library/papers/30862789 | PubMed |
| 30,830,864 | PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells. | JCI Insight | 2019 | https://conductscience.org/library/papers/30830864 | PubMed |
| 30,807,923 | The role of dePARylation in DNA damage repair and cancer suppression. | DNA Repair (Amst) | 2019 | https://conductscience.org/library/papers/30807923 | PubMed |
| 30,567,936 | Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity. | Microbiol Mol Biol Rev | 2019 | https://conductscience.org/library/papers/30567936 | PubMed |
| 30,500,844 | Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice. | PLoS One | 2018 | https://conductscience.org/library/papers/30500844 | PubMed |
| 30,472,116 | (ADP-ribosyl)hydrolases: Structural Basis for Differential Substrate Recognition and Inhibition. | Cell Chem Biol | 2018 | https://conductscience.org/library/papers/30472116 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17526733
GET https://conductscience.org/api/papers/v1/17526733/references?page=2